WGc-043
- Generic Name
- WGc-043
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 19
- Registration Number
- NCT05714748
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath